Bridging the Evidence-to-Execution Gap:A Reflective Agent for Multi-Objective Peptide Design
cs.AI
Submitted: 2026-10-05
Updated: 2026-10-05
Comments: 24 pages, 8 figures
License: http://creativecommons.org/licenses/by/4.0/
The gist: Large language models (LLMs) can reason over scientific literature to devise design strategies, yet fail to reliably implement them for biological sequences.
Abstract
Large language models (LLMs) can reason over scientific literature to devise design strategies, yet fail to reliably implement them for biological sequences. While protein generative models learn sequence patterns, they lack the capacity to incorporate literature evidence for multi-step reflective reasoning, forming an evidence-to-execution gap between scientific reasoning and sequence manipulation. We present EASER (Evidence-Aware Sequence Engineering with Reflection), a reflective agent bridging reasoning and sequence generation via a learned property interface of offline-trained, fixed low-rank matrices. The agent steers a diffusion generator by combining these matrices, proposing intervention hypotheses (anchors, editable positions, control coefficients) grounded in retrieved evidence, sequence context and past results. A Probe-and-Steer mechanism validates interventions and allocates samples according to predicted property responses, with outcome reflection informing subsequent decisions. Evaluated on multi-objective antimicrobial peptide design (optimizing activity, non-hemolysis and non-toxicity), explicit hypothesis formulation delivers better multi-objective performance than direct action generation under identical decision conditions. Ablation studies verify the importance of evidence retrieval, episodic history, reflection and Probe-and-Steer. Over six repeated trials, EASER obtains the highest mean hypervolume and lowest mean IGD+ on screened candidates compared with competing baselines. Our work demonstrates how an executable property interface and iterative feedback link scientific reasoning to targeted peptide sequence generation.
Sources
- Pepti-Agent: An AI Agent for Peptide Design and Optimization
- Classifier-Free Diffusion Guidance
- Agentic Discovery of Non-Canonical Antimicrobial Peptides with AMPGAN v3
- TR2-D2: Tree Search Guided Trajectory-Aware Fine-Tuning for Discrete Diffusion
- AMPBench-MT: A Homology-Controlled Benchmark for Antimicrobial Peptide Potency, Spectrum, and Safety Prediction
Related papers
- MAVEN-T: Reinforced Heterogeneous Distillation for Real-Time Multi-Agent Trajectory Prediction
- Model Discovery Agent: LLM-assisted Bayesian experiment design for data-efficient discovery of mechanistic world models
- Agents' Last Exam
- The Clinician's Veto: Navigating Trust, Liability, and Uncertainty in Autonomous AI Prescribing
- MindHelper: Closed-Loop Embodied Mental-State Reasoning for Precision Intervention
- Incumbent Advantage: Brand Bias and Cognitive Manipulation Dynamics in LLM Recommendation Systems